The following is a guest article by Sid Mehta, President and Chief Growth Officer at Access Healthcare
Why yield is the difference between operating efficiently and getting paid correctly
Cost-to-collect is one of healthcare’s favorite metrics. Boards track it. CFOs benchmark it. Vendors build entire sales pitches around lowering it. And for good reason: knowing what it costs to run your revenue cycle is genuinely useful information.
Here is the problem nobody talks about enough. Many healthcare organizations improve cost-to-collect while cash performance quietly gets worse at the same time.
It’s not a rounding error. It’s a structural blind spot, and it is costing health systems real money.
A revenue cycle can operate cost-effectively and still lose millions in earned reimbursement through denials, underpayments, missed charges, authorization gaps, and unresolved patient balances. The organization may reduce the cost of performing the work yet still under-collect on earned revenue. Efficiency improved. Financial performance did not.
With margin pressure increasing across nearly every health system, organizations frequently prioritize aggressive operational cost reduction. While this focus is understandable, it stops short of the more important question: is the revenue cycle fundamentally protecting the revenue it was built to capture?
This is exactly where the distinction between cost-to-collect and cash-to-net patient revenue becomes worth understanding.
Cost-to-collect measures efficiency
Cost-to-collect measures the operational expense required to run the revenue cycle relative to total patient cash collections. The standard HFMA-aligned formula is straightforward:
Revenue cycle operating expense divided by total patient service cash collected.
Organizations rely on it because it is familiar, widely benchmarked, easy to communicate, and useful for identifying where administrative expense is running too high. Each of those considerations is valid.
However, cost-to-collect has a real limitation unreflective in the formula. It says almost nothing about whether the organization captured the reimbursement it was entitled to receive. It measures how inexpensively the work was completed. It does not measure whether the work protected the dollars at stake.
In today’s payer environment, this precise distinction matters more than it ever has.
The paradox healthcare leaders keep running into
The following scenario plays out more often than many organizations realize.
A hospital reduces billing costs by automating workflows, cutting staff, and shifting work to a lower-cost model. Operationally, it works. Cost-to-collect improves. Administrative expense declines. Productivity metrics look better on the dashboard.
At the same time, eligibility errors increase. Prior authorization gaps create payment delays. Underpayments go unreconciled. Denials sit longer before anyone follows up. Patient balances age without resolution.
So, the organization can say two things that are both completely true: our cost-to-collect improved, and our cash performance declined.
This illustrates the danger of optimizing efficiency focus metrics as a measure of performance. Efficiency asks how economically the work was completed. Financial performance asks whether the work protected and realized the revenue earned. Those are not the same question, and optimizing for one does not automatically improve the other.
Cash-to-net patient revenue measures whether you actually got paid
Cash-to-net patient revenue, commonly called yield, shifts the focus from operational cost to revenue realization. It measures actual cash collected against expected net revenue after contractual adjustments.
In plain terms: out of the revenue your organization realistically expected to receive, how much did you precisely collect?
Yield exposes things cost-to-collect cannot: denials, underpayments, authorization failures, documentation gaps, missed charges, and workflow leakage across the revenue cycle. And unlike efficiency metrics, yield cannot improve unless genuine financial performance improves. As a result, it serves as a much more reliable measure of whether the revenue cycle is functioning as intended.
“The industry is shifting from measuring administrative efficiency to measuring revenue realization,” said Sid Mehta, President and Chief Growth Officer. “Access Healthcare brings automation, operational expertise, and scale to move those numbers without overhauling what is already working.”
A simple example
Take a $100 claim. After contractual adjustments, the expected net reimbursement is $80.
In the first scenario, the organization collects the full $80. Yield is 100%.
In the second scenario, a denial reduces reimbursement to $76. Yield drops to 95%.
In the third scenario, multiple denials and rework reduce reimbursement to $68. Yield falls to 85%.
The charge did not change. The contract did not change. Operational execution changed. This is exactly what yield captures and what cost-to-collect never will: whether the revenue cycle delivered the dollars the organization earned.
Why this is a revenue defense problem
For years, most of the RCM market competed on operational efficiency. Lower labor costs. Offshore staffing. Transaction volume. Incremental automation. The messaging still dominates a lot of vendor conversations because cost reduction is easy to benchmark and easy to sell.
Seemingly running leaner does not automatically improve reimbursement performance. In most organizations, the bigger financial problem is not the administrative cost of processing claims. The bigger problem is the revenue disappearing through preventable leakage across the workflow.
Preventable denials. Incorrect payer reimbursement. Prior authorization gaps. Documentation inconsistencies. Delayed follow-up. Underpayment acceptance. Preventable write-offs resulting from process failure. Most of those losses do not appear in cost-to-collect. They appear in yield.
This is why revenue defense is becoming a more useful frame than operational efficiency for CFOs who want to understand where margin is going. Improving margins is not achieved by minimizing claims processing alone. You improve margins by protecting more of the revenue you truly earned.
When organizations improve documentation quality, reduce denials, strengthen authorization workflows, and identify underpayments before the window closes, two things happen at once: cash performance improves, and cost-to-collect often improves naturally as rework declines. Effectiveness drives efficiency. Chasing efficiency first rarely gets you to effectiveness.
What this means in practice
Healthcare organizations are entering a period where operational efficiency alone is not enough to sustain financial performance. Payer complexity keeps rising. Denial strategies keep evolving. Margins stay compressed. And AI adoption is accelerating on both sides of the transaction, with payers using their own automation to find reasons to reduce or deny payment faster than most provider teams can respond.
The organizations who can outperform in this environment will not necessarily be the ones processing claims at the lowest cost. They will be the ones capturing the highest percentage of the revenue they already earned through better workflow discipline, faster denial intervention, stronger authorization performance, more accurate reimbursement validation, and smarter automation built on top of stable operational foundations.
Cost-to-collect still matters. It is a legitimate operational benchmark and worth tracking. But if it is the primary lens your organization uses to evaluate revenue cycle performance, you are measuring the cost of the work without measuring whether the work is genuinely protecting your revenue.
Yield reveals this insight, and at present it is the more important metric.
About Access Healthcare
Access Healthcare delivers technology as a service, combining automation, analytics, and operational expertise to drive visible results. This summer, we’re introducing a new AI-Embedded RCM Operating Model focused on delivering smoother, cleaner workflows across the RCM cycle by utilizing the combination of AI, automation, and human expertise. If you’ll be at the HFMA Annual Conference, stop by booth #337 to talk more with us about the importance of Yield and how it can benefit your organization. If you’re not at the conference, reach out to us at Access Healthcare: https://www.accesshealthcare.com/about/contact
